Medpace Holdings (MEDP) Change in Receivables (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Change in Receivables data on file, last reported at $47.2 million in Q2 2026.

• Quarterly Change in Receivables fell 40.96% year-over-year to $47.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $63.6 million (down 17.43% YoY) and the FY2025 annual result came in at $106.2 million, up 4837.51% from the prior year.
• Change in Receivables improved to $47.2 million in Q2 2026, from -$7.8 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $79.9 million in Q2 2025 to a low of -$19.1 million in Q1 2024.
• A 5-year average of $14.4 million and a median of $9.6 million in 2023 frame the typical range for Change in Receivables.
• Annual changes were most pronounced in 2022 — Change in Receivables jumped 7103.12% — and 2024, when it slumped 540.06%.
• Tracing MEDP's Change in Receivables over 5 years: stood at $4.5 million in 2022, then surged by 100.09% to $9.0 million in 2023, then tumbled by 270.32% to -$15.3 million in 2024, then soared by 290.49% to $29.1 million in 2025, then jumped by 62.16% to $47.2 million in 2026.
• The last three Change in Receivables figures came in at $47.2 million (Q2 2026), -$7.8 million (Q1 2026), and $29.1 million (Q4 2025), per Business Quant data.